How many clinical trials are tracked of idarubicin?

38 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Urology Hematology Ophthalmology Dermatology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

idarubicin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of idarubicin

38 trials tracked of idarubicin: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 32 citations.

38Trials tracked

2Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 3 2 Phase 2 34 Phase 1 1 Other / NA 1

Show 32 more trials

Phase 2 Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML Completed
Phase 2 Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia Completed
Phase 2 Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Completed
Phase 2 Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction Completed
Phase 2 Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II Completed
Phase 2 Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia Completed
Phase 2 Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia Completed
Phase 2 Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Completed
Phase 2 Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia Completed
Phase 2 Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) Completed
Phase 2 Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia Completed
Phase 2 Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) Completed
Phase 2 Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia Completed
Phase 2 Adoptive Transfer of Haplo-identical DLI for AML and MDS Completed
Phase 2 Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia Completed
Phase 2 Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS Completed
Phase 2 A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia. Completed
Phase 2 Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML Completed
Phase 2 Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia Completed
Phase 2 Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R Completed
Phase 2 Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia Completed
Phase 2 E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes Completed
Phase 2 Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Completed
Phase 2 Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia Completed
Phase 2 S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia Completed
Phase 2 All-trans Retinoic Acid, and Arsenic +/- Idarubicin Completed
Phase 2 A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations Completed
Phase 2 A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) Completed
Phase 2 Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) Completed
Phase 2 A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia Completed
Phase 1 Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Completed
N/A Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Completed

Showing the 38 most-cited and recently-updated of 38 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.